Management lifted its profit outlook, and investors have more than quadrupled that bet. The question now is what they’re really paying for.

When Eli Lilly (LLY)’s management told Wall Street on Apr 30, 2026, that they saw a clearer path to higher profits for 2026, the market didn’t just listen, it sprinted. Since that day, the stock is up meaningfully, tacking on a massive gain. That’s a handsome reward for a company that raised its full-year EPS guidance.

You don’t need a math degree to see the gap there. A bump in the profit forecast sparked a rally more than four times as large. This isn’t just about a simple guidance beat. The market is telling you it believes this is the start of something much bigger. The question for…